Federal contract award
75N91021C00013
PURPOSE: TO PROVIDE CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $71.3M |
| Current contract value | $71.3M |
| Potential contract value / ceiling | $115.5M |
| Start date | Jul 1, 2021 |
| Current end date | Jun 30, 2027 |
| Potential end date | Jun 30, 2031 |
| Latest award activity | Jul 23, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 23, 2026 | P00011 | $0 | EO 14398 CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Jun 24, 2026 | P00010 | $9.9M | CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Apr 28, 2026 | P00009 | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CCR, AND CCR INVESTIGATORS |
| Jul 1, 2025 | P00008 | $9.6M | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CCR, AND CCR INVESTIGATORS |
| Apr 11, 2025 | P00007 | $0 | CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Jun 28, 2024 | P00006 | $12.3M | CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Jun 15, 2023 | P00005 | $13.6M | CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Jun 24, 2022 | P00004 | $13.2M | EO14042-CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Feb 23, 2022 | P00003 | $0 | EO14042-CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Oct 28, 2021 | P00002 | $0 | EO14042-CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Aug 13, 2021 | P00001 | $9.6M | PURPOSE: TO PROVIDE CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
| Jun 29, 2021 | 0 | $3.2M | PURPOSE: TO PROVIDE CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. |
Estimated positioning window
Jun 30, 2030 – Dec 30, 2030
Recompete signal: . Rule-based research score; positioning dates are estimates.
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2031-06-30 (1709 days from calculation)
- +5 points
- 22 historical awards in this buyer and category group
- +15 points
- 12 recorded award transactions
- +10 points
- Latest award action: 2026-07-23
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Paula Wilkison | Contact | paula.wilkison@nih.gov (240) 276-7386 | Source | Nov 3, 2020 |
| Sara McLaurin | Contact | sara.mclaurin@nih.gov (240) 276-5438 | Source | Nov 3, 2020 |
| Paula Wilkison | Contact | paula.wilkison@nih.gov (240) 276-7386 | Source | Oct 5, 2020 |
| Sara McLaurin | Contact | sara.mclaurin@nih.gov (240) 276-5438 | Source | Oct 5, 2020 |
| Paula Wilkison | Contact | paula.wilkison@nih.gov (240) 276-7386 | Source | Sep 25, 2020 |
| Sara McLaurin | Contact | sara.mclaurin@nih.gov (240) 276-5438 | Source | Sep 25, 2020 |
| Paula Wilkison | Contact | paula.wilkison@nih.gov (240) 276-7386 | Source | Aug 24, 2020 |
| Sara McLaurin | Contact | sara.mclaurin@nih.gov (240) 276-5438 | Source | Aug 24, 2020 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.